Immix Biopharma reported total assets of $239.11M and total liabilities of $10.19M for the quarter ended Jun 2026. This balance sheet covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.01M | ||||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 17.64M | 19.06M | 18.40M | 16.92M | 13.44M | 11.46M | 12.65M | 19.58M | 17.51M | 29.32M | 23.98M | 19.69M | 17.68M | 15.92M | 11.64M | 15.95M | 93.93M | 90.60M | 232.10M | ||||
| Prepaid Assets | 0.52M | 0.89M | 0.52M | 0.29M | 1.21M | 1.25M | 2.56M | 2.10M | 1.11M | 1.57M | 1.38M | 1.09M | 0.54M | 0.86M | 0.69M | 0.64M | 0.83M | 1.70M | 1.68M | ||||
| Current Assets | 18.19M | 20.01M | 19.08M | 17.39M | 14.90M | 13.03M | 15.51M | 22.33M | 19.79M | 32.92M | 27.33M | 22.76M | 20.20M | 16.78M | 12.33M | 16.58M | 101.24M | 92.27M | 233.79M | ||||
| Non-Current Assets | |||||||||||||||||||||||
| Construction in Progress | 0.31M | ||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.05M | 0.00M | 0.04M | 0.05M | 0.36M | 0.45M | 1.36M | 1.74M | 2.12M | 2.23M | 2.36M | 2.52M | 2.43M | 2.36M | ||||
| Long-Term Investments | 2.10M | ||||||||||||||||||||||
| Other Non-Current Assets | 0.01M | 0.18M | 0.06M | 0.10M | 0.09M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.11M | 0.11M | 0.09M | 0.16M | 0.02M | ||||||||
| Non-Current Assets | 0.01M | 0.01M | 0.00M | 0.00M | 0.01M | 0.18M | 0.06M | 0.14M | 0.14M | 1.43M | 1.51M | 2.39M | 2.75M | 3.11M | 3.31M | 3.50M | 3.60M | 3.54M | 5.32M | ||||
| Assets | 18.19M | 20.02M | 19.09M | 17.40M | 14.91M | 13.21M | 15.57M | 22.47M | 19.93M | 34.35M | 28.84M | 25.14M | 22.95M | 19.89M | 15.64M | 20.08M | 104.84M | 95.82M | 239.11M | ||||
| Liabilities | |||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||
| Accounts Payables | 0.14M | 0.31M | 0.98M | 0.65M | 1.27M | 1.47M | 2.40M | 2.83M | 3.72M | 5.62M | 3.85M | 6.50M | 8.62M | 9.24M | 9.94M | 10.71M | 9.97M | 10.41M | 9.19M | ||||
| Notes Payables | 0.05M | 0.05M | |||||||||||||||||||||
| Payables | 0.19M | 0.36M | 0.98M | 0.65M | 1.27M | 1.47M | 2.40M | 2.83M | 3.72M | 5.62M | 3.85M | 6.50M | 8.62M | 9.24M | 9.94M | 10.71M | 9.97M | 10.41M | 9.19M | ||||
| Accumulated Expenses | 0.01M | 0.01M | 0.44M | 0.10M | 0.58M | 0.58M | 0.17M | 0.20M | 0.66M | 0.73M | 0.70M | 0.44M | 0.94M | 0.88M | 0.17M | ||||||||
| Short term Debt | |||||||||||||||||||||||
| Current Leases | 0.03M | 0.05M | 0.06M | 0.07M | 0.07M | 0.07M | 0.14M | 0.14M | 0.13M | 0.11M | |||||||||||||
| Total Current Liabilities | 0.20M | 0.37M | 0.98M | 0.65M | 1.27M | 1.47M | 2.40M | 2.83M | 3.72M | 5.66M | 3.90M | 6.56M | 8.69M | 9.31M | 10.01M | 10.85M | 10.11M | 10.54M | 9.30M | ||||
| Non-Current Liabilities | |||||||||||||||||||||||
| Minority Interest | -0.03M | -0.06M | -0.12M | -0.20M | -0.28M | ||||||||||||||||||
| Operating Leases | 1.06M | 1.04M | 1.03M | 1.01M | 0.99M | 0.97M | 0.97M | 0.93M | 0.91M | 0.89M | |||||||||||||
| Other Non-Current Liabilities | 23.41M | ||||||||||||||||||||||
| Total Non-Current Liabilities | -23.21M | 1.75M | 3.72M | 6.72M | 4.94M | 7.59M | 9.70M | ||||||||||||||||
| Total Liabilities | 6.20M | 0.20M | 0.37M | 0.98M | 0.65M | 1.75M | 1.47M | 2.40M | 2.83M | 3.72M | 6.72M | 4.94M | 7.59M | 9.70M | 10.30M | 10.98M | 11.82M | 11.04M | 11.45M | 10.19M | |||
| Shareholder's Equity | |||||||||||||||||||||||
| Total Debt | 0.05M | 0.05M | |||||||||||||||||||||
| Common Equity | -6.20M | 17.99M | 19.65M | 18.11M | 16.75M | 13.16M | 11.74M | 13.17M | 19.65M | 16.20M | 27.63M | 23.89M | 17.55M | 13.25M | 9.59M | 4.65M | 8.26M | 93.80M | 84.36M | 228.92M | |||
| Liabilities and Shareholders Equity | 18.19M | 20.02M | 19.09M | 17.40M | 14.91M | 13.21M | 15.57M | 22.47M | 19.93M | 34.35M | 28.84M | 25.14M | 22.95M | 19.89M | 15.64M | 20.08M | 104.84M | 95.82M | 239.11M | ||||
| Treasury Shares | 0.04M | 0.04M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | -0.07M | -0.07M | -0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | ||||||
| Retained Earnings | 47.62M | 50.60M | 50.71M | 50.93M | 51.16M | 52.25M | 57.29M | 68.15M | 69.78M | 86.59M | 86.93M | 87.67M | 88.37M | 89.24M | 90.87M | 102.07M | 198.29M | 198.90M | 355.00M |